These data indicate that activin A/B and its pathway marker, FLRG, correlate with need for greater supplemental oxygen requirements, but PAI-1, which is elevated in COVID-19 patients relative to healthy subjects, is not linked with the need for greater oxygen in hospitalized patients. Here, SERPINE1 is linked to COVID-19.